◀ Back to MTOR

BCL3 — MTOR

Text-mined interactions from Literome

Tirado et al., Oncogene 2005 : Transient transfection studies using kinase-dead and rapamycin-resistant forms of mTOR demonstrated that only the downregulation of Bcl-xL was caused by the mTOR inhibitory action of rapamycin, which prevented cap dependent translation initiation, whereas Bax upregulation was induced by rapamycin through a mechanism independent of its mTOR inhibitory activity
Weyrich et al., Blood 2007 : mTOR dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets
Ramanathan et al., Proc Natl Acad Sci U S A 2009 : Bcl-xl, but not VDAC1, is a kinase substrate for mTOR in vitro, and mTOR regulates the association of Bcl-xl with mTOR
Rahmani et al., Cancer Res 2013 (Leukemia, Myeloid) : PI3K/mTOR inhibitors markedly downregulated Mcl-1 but increased Bim binding to Bcl-2/Bcl-xL ; the latter effect was abrogated by ABT-737